Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Abaco Systems introduces ImageFlex version 2.0 image processing toolkit March 28, 2018 Flintec introduces UXT family of tension load cells June 26, 2019 The Need for Green in 3D Printing July 29, 2019